Patent On AIDS Drug Will Not Limit Access In India, Industry Argues
It is “misleading” and “counter-productive” to assert that a pharmaceutical company’s filing for a patent on a HIV/AIDS drug in India will limit access to the drug in the future, GlaxoSmithKline said in response to an objection submitted today in…
